Avelumab and Radiation in Muscle-Invasive Bladder Cancer
Clinical trial NCT03747419 · TERMINATED
Trial details
- NCT number
- NCT03747419
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-13
- Primary completion
- 2025-02-24
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.